Search
Roche agrees to acquire PathAI for $750 million
2 day ago /
Read about 0 minute
Author：小编
On May 7, 2026, Roche announced that it has signed a definitive merger agreement to acquire PathAI, a US-based digital pathology company, for an upfront payment of $750 million and performance milestone payments of up to $300 million. The transaction is expected to close in the second half of 2026. Upon completion of the deal, PathAI will become part of Roche's Diagnostics business segment. PathAI's AISight IMS software integrates artificial intelligence analysis capabilities in digital pathology laboratories.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
